Dark Forest Capital Management LP Ocular Therapeutix, Inc Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.2 - $8.69 $33,646 - $69,615	-8,011 Reduced 39.28%	12,383 $84,000
Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $78,516 - $222,906	20,394 New	20,394 $185,000
Q1 2022 May 13, 2022	SELL	$4.83 - $7.35 $937 - $1,425	-194 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$6.16 - $12.07 $12,276 - $24,055	-1,993 Reduced 91.13%	194 $1,000
Q3 2021 Nov 12, 2021	BUY	$9.7 - $14.34 $21,213 - $31,361	2,187 New	2,187 $212,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.